CClinicalTrials.gg
CompletedNCT04509245CH_DDZUpdated Jun 5, 2023

The Effects of a Novel Lifestyle Intervention Program on Insulin Sensitivity in Type 2 Diabetes

An interventional study of Low-calorie diet supported by an app-guided digital education program, nutritional coaching calls via phone in Type 2 Diabetes and Fatty Liver, Nonalcoholic, sponsored by German Diabetes Center. Completed at 1 site in Germany. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2023-06-05.

Sponsored by German Diabetes Center · Not applicable, Interventional, and Basic science

From the registry’s dates

  • Registered 1 year 10 months after the study started (first participant enrolled Oct 2018, registered Aug 2020).
Phase
Not applicable
Study type
Interventional
Enrollment
24
Allocation
Not applicable
Ages
18 Years to 65 Years
Sex
All
01

Study summary

Moderate weight reduction by a moderately hypocaloric very-low-fat diet resulted in normalization of fasting hyperglycemia and reversal of hepatic insulin resistance in patients with poorly controlled type 2 diabetes. The Diabetes Remission Clinical Trial (DiRECT) revealed that utilizing a total diet replacement by a low-energy formula diet for 3 months led to a 15 kg or more weight loss in 24% participants and diabetes remission 46% of the participants. To date it remains unknown whether similar results can be achieved with a natural, non-formula based diet in connection with an educative smartphone application and telephone coaching

Read the detailed description

24 patients with type 2 diabetes from the German Diabetes Study (GDS) with less than 4 years disease duration and not receiving insulin were included in this study. Before the start of the intervention, participants documented their dietary intake by recording a food diary. During the 12-week intervention participants were asked to adhere to a real food-based low-calorie diet supported by an app-guided digital education program as well as a low-calorie recipe book and received weekly coaching calls by nutritionists. Patients were instructed to adhere to a balanced low calorie diet during the intervention. Nutritionists provided structured behavior change focusing on dietary advice, adherence to logging dietary intake and tracking weight. At first visit, patients installed the Changing Health App (Changing Health, Newcastle, UK) and completed an app-based digital education program. This program focused on type 2 diabetes education and behavioral change in combination with weight tracking and dietary monitoring. Patients used the app throughout the study and adherence was monitored via logins. Comprehensive testing before and after the intervention comprised a mixed-meal tolerance test and liver fat.

02

Conditions studied

03

In context

Fatty Liver

1,451 studies on the registry are indexed under Fatty Liver; 292 are open to participants now.

This study's enrollment of 24 is below the median of 60 across 1,003 interventional studies indexed under Fatty Liver.

Browse Fatty Liver studies →

Lead sponsor

German Diabetes Center is the lead sponsor of 27 studies on the registry; 6 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Age between 18 and 65 years
  • Existing diagnosis of type 2 diabetes
  • Individuals who use a smartphone or PC to install the app
  • Individuals who are able to communicate in German

Exclusion criteria

Exclusion Criteria:

  • Physical disability that leads to a significant lack of mobility (wheelchair, walking aid, walking stick, cane or crutches)
  • Insulin therapy
05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
24 participants (actual)

Study arms

  • Experimental
    Effects of a digitally assisted lifestyle intervention

    Testing the effects of a low-calorie diet in connection with app-based digital education and behavioral change program on glucose metabolism and disease management.

    Behavioral: Low-calorie diet supported by an app-guided digital education program, nutritional coaching calls via phone

Interventions

  • BehavioralLow-calorie diet supported by an app-guided digital education program, nutritional coaching calls via phone

    During the 12-week intervention participants were asked to adhere to a real food-based low-calorie diet supported by an app-guided digital education program as well as a low-calorie recipe book and received weekly coaching calls by nutritionists

06

What researchers measure

Primary outcomes

  1. Change in insulin sensitivity

    Change in insulin sensitivity can be estimated via a mixed-meal tolerance test, a standardized liquid meal consumed by the participants

    Time frame: Change in insulin sensitivity after 12 weeks of intervention

Secondary outcomes

  1. Change in öiver fat

    Change in liver fat content was estimated from 1-Proton-Magnetic Resonance Spectroscopy in a human scanner

    Time frame: Change in liver fat after 12 weeks of intervention

07

Study locations

1 site
  • DDZ (Deutsches Diabetes Zentrum)
    Düsseldorf, NRW 40225, Germany
08

References and documents

Publications

  • Zaharia OP, Kupriyanova Y, Karusheva Y, Markgraf DF, Kantartzis K, Birkenfeld AL, Trenell M, Sahasranaman A, Cheyette C, Kossler T, Bodis K, Burkart V, Hwang JH, Roden M, Szendroedi J, Pesta DH. Improving insulin sensitivity, liver steatosis and fibrosis in type 2 diabetes by a food-based digital education-assisted lifestyle intervention program: a feasibility study. Eur J Nutr. 2021 Oct;60(7):3811-3818. doi: 10.1007/s00394-021-02521-3. Epub 2021 Apr 11. PubMed 33839905 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 5, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04509245
Lead sponsor
German Diabetes Center
Responsible party
Sponsor
First posted
Aug 12, 2020
Start date
Oct 1, 2018
Primary completion
Jul 31, 2019
Completion
Dec 1, 2019
Last update
Jun 5, 2023

Study contacts

Michael Roden, MD
principal investigator · German Diabetes Center

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion